Ror1 Targeting Monoclonal Antibodies Induced Apoptosis of Chronic Lymphocytic Leukemia Cells– A Potential Novel Therapeutic Approach
Hodjattallah Rabbani(Karolinska University Hospital), Håakan Mellstedt(Karolinska University Hospital), Amir Hossein Daneshmanesh(Karolinska University Hospital), Mohammad Hojjat‐Farsangi(Karolinska University Hospital), Anders Österborg(Karolinska University Hospital), Fazel Shokri(Academic Center for Education, Culture and Research), Abdul Salam Khan(Karolinska University Hospital), Mahmood Jeddi‐Tehrani(Academic Center for Education, Culture and Research), Mohammad Mehdi Akhondi(The University of Texas Southwestern Medical Center)
Cited by 1
Related Papers
Ofatumumab As Single-Agent CD20 Immunotherapy in Fludarabine-Refractory Chronic Lymphocytic Leukemia
|Journal of Clinical Oncology|2010|587
Nanoparticles and targeted drug delivery in cancer therapy
|Immunology Letters|2017|507
Zanubrutinib or Ibrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2022|453
The significant role of interleukin-6 and its signaling pathway in the immunopathogenesis and treatment of breast cancer
|Biomedicine & Pharmacotherapy|2018|312